undamentalytics Newsletter
Sign in

Seer, Inc. revenue

Seer, Inc.'s revenue was $16.6m in fiscal 2025, up 17.0% on the year before. Since fiscal 2020 ($656,000) it has grown at a compound 90.8% a year. Over the last twelve months it was $14.2m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue171517141714
Growth on the year before—+908.7%+134.1%+7.5%−15.0%+17.0%—
Gross profit1379787
Gross margin100.0%51.6%45.8%51.1%49.8%51.1%47.7%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Seer, Inc. $14.2m -12.7% -5.1%
Bionano Genomics, Inc. $30.2m 10.0% -1.4%
Maxcyte, Inc. $31.1m -13.2% -8.6%
Rapid Micro Biosystems, Inc. $35.2m 16.1% 22.5%
Omniab, Inc. $40.2m 90.6% -14.7%
Alpha Teknova, Inc. $43.7m 12.3% 3.7%

Compare with peers

Head to head: BNGO vs SEERMXCT vs SEERRPID vs SEER

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Seer, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Seer, Inc.